Your browser is no longer supported. Please, upgrade your browser.
DermTech, Inc.
Index- P/E- EPS (ttm)-2.11 Insider Own6.20% Shs Outstand27.15M Perf Week-3.95%
Market Cap953.44M Forward P/E- EPS next Y-2.56 Insider Trans-20.05% Shs Float16.32M Perf Month-15.26%
Income-43.30M PEG- EPS next Q-0.53 Inst Own73.90% Short Float31.21% Perf Quarter-10.74%
Sales6.90M P/S138.18 EPS this Y26.10% Inst Trans0.91% Short Ratio5.86 Perf Half Y-28.45%
Book/sh9.46 P/B3.42 EPS next Y-10.40% ROA-38.00% Target Price- Perf Year168.66%
Cash/sh8.75 P/C3.69 EPS next 5Y- ROE-40.20% 52W Range9.85 - 84.49 Perf YTD-0.37%
Dividend- P/FCF- EPS past 5Y- ROI-55.30% 52W High-61.75% Beta0.80
Dividend %- Quick Ratio36.80 Sales past 5Y- Gross Margin1.00% 52W Low228.09% ATR2.42
Employees118 Current Ratio36.90 Sales Q/Q56.30% Oper. Margin- RSI (14)37.98 Volatility5.76% 7.44%
OptionableYes Debt/Eq0.00 EPS Q/Q-5.40% Profit Margin- Rel Volume0.53 Prev Close32.57
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout- Avg Volume868.63K Price32.32
Recom1.50 SMA20-6.27% SMA50-16.86% SMA200-12.19% Volume464,580 Change-0.77%
May-03-21Initiated BTIG Research Buy $53
Jan-22-21Initiated Oppenheimer Outperform $53
Dec-14-20Initiated Craig Hallum Buy $23
Oct-30-20Initiated William Blair Outperform
Dec-05-19Initiated Lake Street Buy
Aug-04-21 05:25PM  
Jul-28-21 03:03PM  
Jul-26-21 07:40PM  
Jul-21-21 04:30PM  
Jul-19-21 05:52AM  
Jul-18-21 07:57AM  
Jul-06-21 08:00AM  
Jun-24-21 05:00PM  
Jun-23-21 05:52AM  
Jun-22-21 04:30PM  
Jun-16-21 04:01PM  
Jun-05-21 04:54AM  
Jun-04-21 07:30AM  
Jun-02-21 04:30PM  
May-29-21 06:04AM  
May-26-21 07:30AM  
May-21-21 06:31AM  
May-18-21 04:01PM  
May-13-21 05:55PM  
May-11-21 04:01PM  
May-10-21 04:30PM  
May-06-21 03:00PM  
May-04-21 05:55AM  
May-03-21 04:30PM  
Apr-29-21 04:01PM  
Apr-28-21 08:21AM  
Apr-27-21 04:30PM  
Apr-22-21 04:30PM  
Apr-19-21 04:30PM  
Apr-15-21 04:01PM  
Apr-04-21 09:05AM  
Apr-02-21 05:52AM  
Mar-25-21 10:10AM  
Mar-18-21 06:13AM  
Mar-10-21 01:00PM  
Mar-05-21 07:36AM  
Mar-04-21 07:45PM  
Feb-26-21 05:52AM  
Feb-24-21 06:12AM  
Feb-22-21 04:30PM  
Feb-20-21 07:18AM  
Feb-18-21 04:01PM  
Feb-17-21 04:01PM  
Feb-12-21 08:10AM  
Feb-11-21 01:00PM  
Feb-10-21 04:01PM  
Feb-08-21 04:48PM  
Feb-07-21 07:00AM  
Feb-03-21 04:01PM  
Jan-28-21 04:30PM  
Jan-22-21 07:26PM  
Jan-19-21 04:30PM  
Jan-14-21 04:30PM  
Jan-12-21 04:01PM  
Jan-11-21 04:01PM  
Jan-07-21 12:00AM  
Jan-06-21 04:01PM  
Jan-05-21 04:30PM  
Dec-30-20 04:22PM  
Dec-29-20 05:05PM  
Dec-28-20 04:01PM  
Dec-23-20 03:24PM  
Dec-17-20 04:30PM  
Dec-11-20 09:00AM  
Dec-10-20 04:01PM  
Dec-03-20 04:30PM  
Dec-02-20 10:14PM  
Nov-20-20 08:00AM  
Nov-17-20 04:30PM  
Nov-13-20 06:08AM  
Nov-10-20 04:01PM  
Nov-04-20 04:01PM  
Oct-27-20 04:01PM  
Oct-26-20 06:38PM  
Sep-14-20 08:51AM  
Sep-10-20 09:31AM  
Sep-08-20 08:00AM  
Sep-03-20 04:01PM  
Aug-05-20 04:01PM  
Jun-30-20 08:00AM  
Jun-16-20 06:40AM  
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dobak JohnChief Executive OfficerJul 01Sale41.0812,500513,448456,347Jul 02 08:47 PM
PANCOAST SCOTT RDirectorJun 30Sale42.415,000212,05148,290Jul 02 08:50 PM
Wood Todd MichaelChief Commercial OfficerJun 14Sale41.442,590107,322147,736Jun 15 08:13 PM
Wood Todd MichaelChief Commercial OfficerJun 11Sale41.192,19390,324150,326Jun 15 08:13 PM
Sun Kevin MChief Financial OfficerJun 11Sale41.081,93379,412154,478Jun 15 08:12 PM
Dobak JohnChief Executive OfficerJun 11Sale41.087,651314,322468,847Jun 15 08:09 PM
Wood Todd MichaelChief Commercial OfficerJun 08Sale43.4342518,458152,519Jun 10 08:19 PM
Sun Kevin MChief Financial OfficerJun 08Sale43.432,870124,644156,411Jun 10 08:18 PM
Ibarra ClaudiaChief Operating OfficerJun 08Sale43.432,405104,449118,510Jun 10 08:17 PM
Dobak JohnChief Executive OfficerJun 08Sale43.431,11848,555476,498Jun 10 08:16 PM
Dobak JohnChief Executive OfficerJun 02Sale40.009,530381,200477,616Jun 03 08:19 PM
Dobak JohnChief Executive OfficerJun 01Sale40.222,970119,443487,146Jun 03 08:19 PM
Picozza EnricoDirectorMay 26Sale40.0820,297813,577500,000May 28 08:18 PM
Wood Todd MichaelChief Commercial OfficerMay 25Sale40.0010,000400,000152,944May 27 08:08 PM
Picozza EnricoDirectorMay 25Sale40.014,703188,158520,297May 25 06:43 PM
Picozza EnricoDirectorMay 21Sale37.4025,000935,045525,000May 25 06:43 PM
Picozza EnricoDirectorMay 20Sale36.7394,7193,478,803550,000May 20 08:16 PM
Picozza EnricoDirectorMay 19Sale35.66140,0174,993,130644,719May 20 08:16 PM
Picozza EnricoDirectorMay 18Sale37.4221,126790,510784,736May 20 08:16 PM
Dobak JohnChief Executive OfficerMay 03Sale40.9625,0001,023,930490,116May 05 04:19 PM
Dobak JohnChief Executive OfficerApr 27Sale51.3525,0001,283,750515,116Apr 29 04:04 PM
Jacobs Gary E.DirectorApr 19Option Exercise1.1021,84324,117547,438Apr 21 04:46 PM
Wood Todd MichaelChief Commercial OfficerApr 12Sale46.3310,000463,321162,944Apr 14 05:01 PM
Dobak JohnChief Executive OfficerApr 12Sale46.3425,0001,158,500540,116Apr 14 04:59 PM
Wood Todd MichaelChief Commercial OfficerMar 08Sale50.0441720,867164,782Mar 10 05:18 PM
Sun Kevin MChief Financial OfficerMar 08Sale50.042,886144,415151,261Mar 10 05:14 PM
Ibarra ClaudiaChief Operating OfficerMar 08Sale50.042,431121,647114,930Mar 10 05:11 PM
Dobak JohnChief Executive OfficerMar 08Sale50.0478039,031543,071Mar 10 05:09 PM
Jansen BurkhardChief Medical OfficerJan 26Option Exercise6.945,00034,70079,037Jan 28 06:19 PM
Posard Matthew L.DirectorJan 11Buy29.5033,898999,99186,863Jan 13 04:21 PM
RTW INVESTMENTS, LP10% OwnerJan 07Buy29.50200,0005,900,0003,087,216Jan 11 06:04 PM
PANCOAST SCOTT RDirectorDec 14Sale13.936,00083,56944,132Dec 16 04:40 PM
Jansen BurkhardChief Medical OfficerDec 14Sale12.415,00062,05079,037Dec 16 04:36 PM
Jansen BurkhardChief Medical OfficerDec 11Sale12.205,00061,00074,037Dec 17 08:11 PM
Wood Todd MichaelChief Commercial OfficerDec 08Sale11.864285,076165,199Dec 10 04:10 PM
Ibarra ClaudiaChief Operating OfficerDec 08Sale11.862,42128,713115,246Dec 10 04:08 PM
Dobak JohnChief Executive OfficerDec 08Sale11.867869,322541,683Dec 10 04:06 PM
PANCOAST SCOTT RDirectorDec 07Sale12.002,38228,58450,132Dec 09 04:44 PM
Jacobs Gary E.DirectorOct 26Option Exercise1.08692747523,903Oct 28 04:11 PM
Wood Todd MichaelChief Commercial OfficerSep 10Sale10.821,34514,558165,627Sep 14 07:38 PM
Dobak JohnChief Executive OfficerSep 10Sale10.822,47026,735542,469Sep 14 07:36 PM
Ibarra ClaudiaChief Operating OfficerSep 10Sale10.827,60582,316117,667Sep 14 07:34 PM